Andreas Segerros

Andreas Segerros

Voorzitter bij DEXTECH MEDICAL AB
65 jaar
Health Technology
Consumer Services
Finance

Profiel

Andreas Rutger Segerros is currently Chief Executive Officer at Sylentis SAU since 2024.
Holds Chairman positions at Oncorena AB, Dextech Medical AB, and Oncorena Holding AB. Serves as Director at Prexton Therapeutics SA. Managing Partner at Eir Ventures Danmark ApS since 2020.
Formerly Chief Executive Officer at Nicox SA from 2022 to 2024.
Served as Chief Executive Officer at Clinitrac AB. Held Chairman role at CMC Contrast AB. Worked as Independent Director at Zyla Life Sciences LLC.
Director at Egalet Ltd. in 2011.
Director at RSPR Pharma AB. Head of Business Development & Operations Planning at Ferring Pharmaceuticals A. Principal at Pharmacia, Inc. Venture Partner at Sunstone Capital A from 2012 to 2019.
Education includes an MBA from the University of Uppsala and graduate studies at the Royal Institute of Technology.

Actieve functies van Andreas Segerros

BedrijvenFunctieBegin
DEXTECH MEDICAL AB Voorzitter -
Voorzitter -
Voorzitter -
Private Equity Investor 01-07-2020
Directeur/Bestuurslid -
Algemeen Directeur 29-05-2024

Eerdere bekende functies van Andreas Segerros

BedrijvenFunctieEinde
NICOX SA Algemeen Directeur 28-02-2024
Private Equity Investor 01-02-2019
Corporate Officer/Principal -
░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░ -
Ervaring van Andreas Segerros in detail bekijken

Opleiding van Andreas Segerros

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

34

Eerstegraads connecties

17

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit17

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Consumer Services

Health Technology

Consumer Services

Pharmacia, Inc.

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

  1. Beurs
  2. Insiders
  3. Andreas Segerros